Molecular structure of Chromeceptin, CAS Number: 331859-86-0
Chromeceptin (CAS 331859-86-0)
See product citations (1)
Alternate Names:
2-Amino-3-cyano-7-dimethylamino-4-(3-trifluoromethylphenyl)-4H-chromene
Application:
Chromeceptin is a cell-permeable benzochromene compound that blocks insulin-induced adipogenesis
CAS Number:
331859-86-0
Molecular Weight:
359.35
Molecular Formula:
C19H16F3N3O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Chromeceptin is a cell-permeable benzochromene compound that blocks insulin-induced adipogenesis in 3T3-L1 cells (100% blockage at ≤ 20 ng/mul) and selectively suppresses IGF2- (insulin-like growth factor 2) dependent growth of HepG2 carcinoma cells (IC50 = 29 nM). Chromeceptin may act to bind to MFP-2 (multifunctional protein-2) and activate STAT6-mediated gene expression, such as IGFBP-1 and SOCS-3, in HepG2 cells. This exceptional innovation serves as a highly selective and potent inhibitor of the vital enzyme monoamine oxidase (MAO). As a pivotal player in the metabolism of neurotransmitters like serotonin and dopamine.
Chromeceptin (CAS 331859-86-0) References
- Chemical genetic identification of the IGF-linked pathway that is mediated by STAT6 and MFP2. | Choi, Y., et al. 2006. Chem Biol. 13: 241-9. PMID: 16638529
- Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. | Ma, N., et al. 2011. Mol Cell Endocrinol. 333: 96-101. PMID: 21146586
- A role for the root cap in root branching revealed by the non-auxin probe naxillin. | De Rybel, B., et al. 2012. Nat Chem Biol. 8: 798-805. PMID: 22885787
- Mislocalization and inhibition of acetyl-CoA carboxylase 1 by a synthetic small molecule. | Jung, D., et al. 2012. Biochem J. 448: 409-16. PMID: 23067267
- Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells. | Huang, CK., et al. 2013. Stem Cell Res. 11: 938-50. PMID: 23859805
- Increased In Vitro Osteopotential in SHED Associated with Higher IGF2 Expression When Compared with hASCs. | Fanganiello, RD., et al. 2015. Stem Cell Rev Rep. 11: 635-44. PMID: 25931278
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma. | Pei, Y., et al. 2016. Cancer Cell. 29: 311-323. PMID: 26977882
- Tubulin is a molecular target of the Wnt-activating chemical probe. | Fukuda, Y., et al. 2016. BMC Biochem. 17: 9. PMID: 27207629
- Inhibition of G0/G1 Switch 2 Ameliorates Renal Inflammation in Chronic Kidney Disease. | Matsunaga, N., et al. 2016. EBioMedicine. 13: 262-273. PMID: 27745900
- NAB2-STAT6 fusion protein mediates cell proliferation and oncogenic progression via EGR-1 regulation. | Park, YS., et al. 2020. Biochem Biophys Res Commun. 526: 287-292. PMID: 32216968
- Loss of miR-100 and miR-125b results in cancer stem cell properties through IGF2 upregulation in hepatocellular carcinoma. | Seol, HS., et al. 2020. Sci Rep. 10: 21412. PMID: 33293585
- The Peroxisomal Localization of Hsd17b4 Is Regulated by Its Interaction with Phosphatidylserine. | Lee, SA., et al. 2021. Mol Cells. 44: 214-222. PMID: 33935042
- Activation of Insulin-Like Growth Factor-2 Ameliorates Retinal Cell Damage and Exerts Protection in in vitro Model of Diabetic Retinopathy. | Zhao, Y., et al. 2021. Neuroimmunomodulation. 28: 266-275. PMID: 33951651
- Time-restricted feeding entrains long-term behavioral changes through the IGF2-KCC2 pathway. | Zhai, Q., et al. 2022. iScience. 25: 104267. PMID: 35521538
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Chromeceptin, 5 mg | sc-202540 | 5 mg | $224.00 | |||
Chromeceptin, 25 mg | sc-202540A | 25 mg | $785.00 |